Article from Seeking Alpha: Cytosorbents latest en
Post# of 102
Jan. 28, 2020 8:06 AM ETCytosorbents Corporation (CTSO)By: Douglas W. House, SA News Editor1 Comment
Thinly traded micro cap Cytosorbents (NASDAQ:CTSO) is up 17% premarket on average volume on the heels of the publication of a report in The Lancet detailing the clinical features of patients in Wuhan, China infected with the coronavirus 2019-nCoV.
The company says levels of circulating inflammatory cytokines are correlated with the severity of illness, providing the rationale for using blood purifier CytoSorb to reduce cytokine levels and ameliorate inflammation.